These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4113442)

  • 21. Effects of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) and its degradation products on progression of L1210 cells through the cell cycle.
    Bray DA; DeVita VT; Adamson RH; Oliverio VT
    Cancer Chemother Rep; 1971 Jun; 55(3):215-20. PubMed ID: 5115843
    [No Abstract]   [Full Text] [Related]  

  • 22. Separate and sequential chemotherapy of mouse leukemia L1210 with 1-beta-D-arabinofuranosylcytosine hydrochloride and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Tyrer DD; Kline I; Venditti JM; Goldin A
    Cancer Res; 1967 May; 27(5):873-9. PubMed ID: 6025252
    [No Abstract]   [Full Text] [Related]  

  • 23. Phase II study of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the treatment of bronchogenic carcinoma.
    Olshin S; Siddiqui S; Firat D
    Cancer Chemother Rep; 1972 Apr; 56(2):259-61. PubMed ID: 5043228
    [No Abstract]   [Full Text] [Related]  

  • 24. Nitrosoureas: 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962; BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC-79037; CCNU)--clinical brochure.
    Carter SK; Newman JW
    Cancer Chemother Rep 3; 1968 Dec; 1(1):115-51. PubMed ID: 4917773
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or cyclophosphamide on spleen colony-forming units and survival time of leukemic mice.
    Vadlamudi S; Waravdekar VS; Choudry JN; Goldin A
    Cancer Res; 1968 Jul; 28(7):1242-9. PubMed ID: 5665982
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and cyclophosphamide (NSC-26271) on nicotinamide adenine dinucleotide glycohydrolase in normal and leukemic mouse tissues.
    Tsukagoshi S; Kao MH; Goldin A
    Cancer Chemother Rep; 1968 Sep; 52(5):569-78. PubMed ID: 5743704
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4].
    Brunner KW; Maurice P; Sonntag RW
    Schweiz Med Wochenschr; 1972 Oct; 102(43):1546-51. PubMed ID: 4647016
    [No Abstract]   [Full Text] [Related]  

  • 28. Topical lomustine in the treatment of psoriasis.
    Peck GL; Guss SB; Key DJ
    Arch Dermatol; 1972 Aug; 106(2):172-6. PubMed ID: 4558698
    [No Abstract]   [Full Text] [Related]  

  • 29. Lack of correlation between clinical and angiographic findings in patients with brain tumors under BCNU chemotherapy.
    Koo AH; Fewer D; Wilson CB; Newton TH
    J Neurosurg; 1972 Jul; 37(1):9-14. PubMed ID: 4338690
    [No Abstract]   [Full Text] [Related]  

  • 30. Phase II study of strepozotocin (NSC-85998) in the treatment of advanced gastrointestinal cancer.
    Moertel CG; Reitemeier RJ; Schutt AJ; Hahn RG
    Cancer Chemother Rep; 1971 Jun; 55(3):303-7. PubMed ID: 5115851
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of combined therapy with cytosine arabinoside (NSC-63878) and l,3-bis-(2-chloroethyl)-1-nitrosourea (NSC-409962) on sarcoma 180 and L1210 in vivo.
    Mizuno NS; Humphrey EW
    Cancer Chemother Rep; 1969 Sep; 53(4):215-21. PubMed ID: 5384462
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on the chemotherapy of experimental brain tumors: evaluation of 1,3-bis(2-chloroethyl)-l-nitrosourea, cyclophosphamide, mithramycin, and methotrexate.
    Shapiro WR; Ausman JI; Rall DP
    Cancer Res; 1970 Sep; 30(9):2401-13. PubMed ID: 5475484
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of chemotherapy and-or head irradiation on survival of mice with intracranial glioma.
    Thomson JM; Maruyama Y; Schwartz S; Hahn E
    Radiology; 1971 Oct; 101(1):187-94. PubMed ID: 4329540
    [No Abstract]   [Full Text] [Related]  

  • 34. "Big" insulin and the treatment of an islet cell carcinoma with streptozotocin.
    Pearson MJ; Larkins RG; Martin FI
    Metabolism; 1972 Jun; 21(6):551-8. PubMed ID: 4337586
    [No Abstract]   [Full Text] [Related]  

  • 35. Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy.
    Mayo JG; Laster WR; Andrews CM; Schabel FM
    Cancer Chemother Rep; 1972 Apr; 56(2):183-95. PubMed ID: 5043226
    [No Abstract]   [Full Text] [Related]  

  • 36. 5-Fluorouracil (5-Fu; NSC-19893), 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388), vincristine (NSC-67574), and 1,3-bis(2-chloroethyl)-2-nitrosourea (BCNU; NSC-409962) given concomitantly in the treatment of solid tumors in man.
    van Eden EB; Falkson G; van Dyk JJ; van der Merwe AM; Falkson HC
    Cancer Chemother Rep; 1972 Feb; 56(1):107-47. PubMed ID: 5030803
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of tumor-host differences at a single histocompatibility locus (H-1) on the antileukemic effect of 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC 409962).
    Bonmassar E; Cudkowicz G; Vadlamudi S; Goldin A
    Cancer Res; 1970 Oct; 30(10):2538-42. PubMed ID: 5474176
    [No Abstract]   [Full Text] [Related]  

  • 38. [The organotropy of alkylating activity of dimethylnitrosamine (DMNA) and nitrosomethyl urea (NMH) in vivo].
    Krüger FW; Osswald H; Walker G; Schelten E
    Z Krebsforsch; 1970; 74(4):434-47. PubMed ID: 4253315
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of Hodgkin's disease.
    Carter SK; Goldsmith MA
    Lancet; 1973 Feb; 1(7797):264. PubMed ID: 4119407
    [No Abstract]   [Full Text] [Related]  

  • 40. Notes on streptozotocin in metastatic insulinoma.
    Vogel TT
    J Surg Oncol; 1971; 3(5):481-5. PubMed ID: 4329781
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.